<DOC>
	<DOCNO>NCT00738569</DOCNO>
	<brief_summary>The purpose study determine whether add Raltegravir fully suppressive antiretroviral regimen assist reduce HIV-1 associated chronic inflammation increase t-lymphocyte memory cell pool .</brief_summary>
	<brief_title>Assess Downregulation HIV-1 When Raltegravir Added Virologically Suppressed HAART Regimen</brief_title>
	<detailed_description />
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>1 . At least 18 year age 2 . HIVpositive Western blot viral load 3 . Viral load &lt; 400 copies/ml 4 . CD4+ Tlymphocyte count le 350 cells/mm3 change CD4+ Tlymphocyte count &lt; 100 cells/mm3 least one year stable HAART viral load &lt; 400 copies/ml period time 1 . CD4+ Tlymphocyte count great equal 350 cells/mm3 rise CD4+ Tlymphocyte count great equal 100 cells/mm3 within one year study entry 2 . Viral load &gt; 400 copies/ml 3 . Allergy resistance raltegravir</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Chronic inflammation</keyword>
	<keyword>memory cell</keyword>
	<keyword>activate t-lymphocytes</keyword>
</DOC>